Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
Fig. 2B B'B'' E E'E''
Kreis J et al. (2021)
|
Xla Wt + rab7a MO
NF13 (in situ hybridization)
|
|
|
|
Fig. 3A, row3, col3
Chang LS et al. (2020)
|
Xtr WT + ptprk MO
NF 10.5 (in situ hybridization)
|
|
|
|
Fig. 3. supp1 C
Chang LS et al. (2020)
|
Xtr WT + ptprk MO
NF 10.5 (in situ hybridization)
|
|
|
|
Fig 3 F
Kirsch N et al. (2017)
|
Xtr Wt + angptl4
NF11 (in situ hybridization)
|
|
|
|
Fig S3 C
Kirsch N et al. (2017)
|
Xtr Wt + angptl4 MO
NF11-18 (in situ hybridization)
|
|
|
|
fig.7.c
Liu C et al. (2016)
|
Xla Wt + miR-26
NF11 (in situ hybridization)
|
|
|
|
fig.6.h
Liu C et al. (2016)
|
Xla Wt + smad1 MO
NF11 (in situ hybridization)
|
|
|
|
Fig. S1 B, C, D, E
Walentek P et al. (2013)
|
Xla Wt + wnt11b MO
NF10-10.5 (in situ hybridization)
|
|
|
|
fig.8.b, b^1
Liu C et al. (2012)
|
Xla Wt + map3k7 MO
NF10-10.25 (in situ hybridization)
|
|
|